Sumatriptan Succinate
Product Images NDC 53002-1592

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 53002-1592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
Line graph depicting the estimated probability of response over time in minutes from initial dose for Sumatriptan Succinate. The graph compares placebo and three dosage levels: 25 mg, 50 mg, and 100 mg. The vertical axis shows the estimated probability of response, and the horizontal axis shows time in minutes up to 240.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph showing the estimated probability of remediation or rescue over time in hours from initial dose. The graph compares placebo and Sumatriptan Succinate doses of 25 mg, 50 mg, and 100 mg, illustrating their respective probabilities across a 24-hour period.*
FDA Label Image

Label Image (Lbl530021592)

Label Image (Lbl530021592)
Sumatriptan 50mg tablets packaging label from RPK Pharmaceuticals, Inc. The label indicates a patient pack containing 9 tablets with instructions to take as directed on the package. The label includes dosage strength, quantity, and manufacturer details with additional handling and safety information.*
FDA Label Image

Label Image (Lbl530021593)

Label Image (Lbl530021593)
Sumatriptan Succinate 25mg tablets packaging label from RPK Pharmaceuticals, Inc. It is a patient pack containing 9 tablets. The label includes directions to take as directed on the package, barcode, lot number, and billing NDC information. The label references its use for the treatment of acute migraine headaches and includes storage instructions.*
FDA Label Image

Label Image (Lbl530022562)

Label Image (Lbl530022562)
Packaging label for Sumatriptan Succinate 100mg tablets, distributed by RPK Pharmaceuticals, Inc. The label indicates a 1-pack patient pack of Sumatriptan 100mg tablets, Rx only. It includes instructions to take as directed on the package and lists contents per tablet. The label features multiple NDCs and packaging details such as lot number, expiration date, and storage instructions.*
FDA Label Image

Strucure (Structure)

Strucure (Structure)
Chemical structure of sumatriptan succinate, depicting the molecular arrangement of its active ingredient components, including the indole ring, sulfonamide, and succinate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.